- Home
- NVCT vs CTKB Comparison
NVCT vs CTKB Comparison
Compare NVCT & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | CTKB |
|---|---|---|
| Founded | 2020 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.7M | 541.1M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NVCT | CTKB |
|---|---|---|
| Price | $24.19 | $4.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $5.63 |
| AVG Volume (30 Days) | 184.1K | ★ 819.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $5.55 | $3.28 |
| 52 Week High | $29.28 | $6.18 |
Technical Indicators
Market Signals| Indicator | NVCT | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 50.53 |
| Support Level | $17.98 | $4.56 |
| Resistance Level | $25.94 | $4.70 |
| Average True Range (ATR) | 1.60 | 0.24 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 76.04 | 50.00 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.